Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 13 save search
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
Published: 2021-09-13 (Crawled : 12:00) - biospace.com/
BLU | $14.74 0.03% 0
|
Health Technology
|
| O: 20.66%
H: 8.88%
C: 1.06%
phase 2 positive chronic cough phase 2b trial blu-5937
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
Published: 2021-09-13 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 14.96%
H: 47.46%
C: 45.24%
phase 1 positive trial phase 1b phase 2b response
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Positive Data from a Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response of ATYR1923 in Pulmonary Sarcoidosis
Published: 2021-09-13 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 14.96%
H: 47.46%
C: 45.24%
biopharma phase 1 positive trial phase 1b phase 2b
Adaptimmune Announces Clinical Responses across Five Solid Tumor Indications with an Overall Response Rate of 36% and Promising Early Durability from its Next-Generation SURPASS Trial
Published: 2021-09-13 (Crawled : 14:00) - biospace.com/
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 9.12%
H: 0.29%
C: -14.22%
trial solid tumors response
NAPCO Announces Fourth Quarter and Fiscal 2021 Results
Published: 2021-09-13 (Crawled : 12:15) - prnewswire.com
NSSC | $40.04 0.78% 0.77% 710K
|
Producer Manufacturing
|
| O: 7.87%
H: 7.66%
C: 7.52%
results
Matinas BioPharma Announces Positive Data in the Ongoing EnACT Trial of MAT2203 (Oral Amphotericin B) for the Treatment of Cryptococcal Meningitis, Exceeding the Prespecified Primary Endpoint Threshold
Published: 2021-09-13 (Crawled : 11:00) - globenewswire.com
MTNB | $0.1877 -1.21% 0.0% 330K
|
Health Technology
|
| O: 7.75%
H: 23.6%
C: 17.98%
treatment biopharma ongoing positive trial mat2203
Brooge Energy Reports Revenue of $23.3 Million for the Six Months Ended June 30, 2021
Published: 2021-09-13 (Crawled : 15:00) - globenewswire.com
BROG | $1.11 0.0% 730K
|
Finance
|
| O: 6.66%
H: 0.0%
C: -5.42%
energy
Additional Data from Hepion Pharmaceuticals’ Phase 2a ‘AMBITION’ Trial Further Strengthens CRV431 Clinical Profile and Paves Way for Initiation of Phase 2b ‘ASCEND-NASH’ Clinical Program
Published: 2021-09-13 (Crawled : 19:00) - biospace.com/
HEPA | News | $2.11 -0.09% -0.09% 73K
|
Health Technology
|
| O: 4.82%
H: 0.57%
C: -3.45%
phase 2 phase 2b nash trial crv431
SeaChange Reports Fiscal Second Quarter 2022 Financial and Operational Results
Published: 2021-09-13 (Crawled : 21:00) - globenewswire.com
SEAC | $4.88 -1.84% 22K
|
Electronic Technology
|
| O: 4.59%
H: 10.53%
C: -0.88%
results
Datasea Announces a $4.33 Million New Contract to Provide Short Message and 5G Multimedia Message Services
Published: 2021-09-13 (Crawled : 13:00) - globenewswire.com
DTSS | $7.3 -3.05% -3.15% 34K
|
Technology Services
|
| O: 4.37%
H: 28.84%
C: 12.56%
media 5g contract new contract
ABVC BioPharma Completes Site Selection for ABV-1505 ADHD Phase II Part 2 Clinical Study
Published: 2021-09-13 (Crawled : 16:00) - biospace.com/
ABVC | $0.9899 -5.72% -6.07% 160K
|
Wholesale Trade
|
| O: 4.05%
H: 0.53%
C: -10.18%
biopharma adhd
Diana Shipping Inc. Announces Time Charter Contract for m/v Amphitrite With BG Shipping
Published: 2021-09-13 (Crawled : 14:00) - globenewswire.com
DSX | $2.9 0.35% -0.69% 330K
|
Transportation
|
| O: 3.99%
H: 3.66%
C: 2.79%
contract
Dream Finders Homes to Acquire the Assets of McGuyer Homebuilders, Inc. (MHI)
Published: 2021-09-13 (Crawled : 12:15) - globenewswire.com
DFH 4 | $33.79 -1.17% 0.06% 630K
|
|
| O: 3.64%
H: 0.0%
C: -12.27%
Spectrum Pharmaceuticals Announces Late-Breaking Oral Presentation of Data for Poziotinib in First-Line NSCLC Patients with HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2021
Published: 2021-09-13 (Crawled : 12:00) - biospace.com/
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 3.62%
H: 0.44%
C: -2.18%
presentation iot poziotinib her2+ her2- her2
Data Center Server Market 2021-2025 | Cisco Systems Inc. and Dell Technologies Inc. to emerge as dominant players | 17,000+ Technavio Research Reports
Published: 2021-09-13 (Crawled : 08:00) - prnewswire.com
DELL | News | $114.87 -2.96% -0.09% 9.4M
|
Electronic Technology
|
| O: 3.31%
H: 1.03%
C: 0.51%
research merge
LMP Announces a Definitive Acquisition Agreement to Purchase an 85% Interest in the Alan Jay Automotive Network, a 12-Dealership Group in Florida, Along with the Associated Real Estate, Generating Approximately $345 Million in Annualized Re
Published: 2021-09-13 (Crawled : 12:00) - globenewswire.com
LMPX | $0.1055 1200.0% 300
|
Technology Services
|
| O: 3.27%
H: 7.87%
C: 5.19%
acquisition
LMP Announces a Definitive Acquisition Agreement to Purchase 5 Import Dealerships in Texas, Along with the Associated Real Estate, Generating Approximately $592 Million in Annualized Revenue and $35 Million in Adjusted EBITDA
Published: 2021-09-13 (Crawled : 14:00) - globenewswire.com
LMPX | $0.1055 1200.0% 300
|
Technology Services
|
| O: 3.27%
H: 7.87%
C: 5.19%
acquisition
Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-1800 as a Potential Vaccine to Prevent COVID-19
Published: 2021-09-13 (Crawled : 12:15) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 3.05%
H: 1.38%
C: -3.69%
covid fda potential results vaccine
Dana Accelerates Electrification of Underground Mining Vehicles with New High-Efficiency e-Powershift Transmission
Published: 2021-09-13 (Crawled : 12:00) - prnewswire.com
DAN | $12.15 1.17% -0.25% 1.9M
|
Producer Manufacturing
|
| O: 2.98%
H: 2.06%
C: 1.83%
vehicles
Dana Upgrades Power Density, Torque Range of Brevini™ Helical and Bevel Helical Gearboxes for Industrial Mining Applications
Published: 2021-09-13 (Crawled : 12:00) - prnewswire.com
DAN | $12.15 1.17% -0.25% 1.9M
|
Producer Manufacturing
|
| O: 2.98%
H: 2.06%
C: 1.83%
trial application
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.